Prescription attached:-

đŠē Prescription Review, Drug Analysis & Clinical Working Diagnosis
Based on Harrisonâs Principles of Internal Medicine, Davidsonâs Medicine, EAU Guidelines, ACG Guidelines and MedEx Bangladesh
Author: Md.Rafiqul Islam Lipu
Date: Tuesday, 13 October 2026
Time: 6:02 PM (Bangladesh Time)
Prescription Information
- Prescribing Physician: Dr. Md. Robed Amin, MBBS, FCPS (Medicine)
- Specialty: Medicine Specialist
- Patient: Male
- Age: Approximately 70 years at the time of consultation
- Prescription Date: 23 February 2020
Clinical interpretation notice: āĻāĻāĻŋ ⧍ā§Ļ⧍ā§Ļ āϏāĻžāϞā§āϰ āĻāĻāĻāĻŋ āĻĒā§āϰā§āύ⧠āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύāĨ¤ āĻšāĻžāϤā§āϰ āϞā§āĻāĻž āĻāĻŦāĻ āĻāĻŦāĻŋāϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļā§āϰ āĻāĻŋāĻā§ āĻ āĻāĻļ āĻ āϏā§āĻĒāώā§āĻāĨ¤ āϤāĻžāĻ āϝā§āϏāĻŦ āϤāĻĨā§āϝ āϏā§āĻĒāώā§āĻ, āϏā§āĻā§āϞ⧠āĻāϞāĻžāĻĻāĻž āĻāϰā§āĻāĻŋ āĻāĻŦāĻ āĻ āύāĻŋāĻļā§āĻāĻŋāϤ āĻ āĻāĻļā§ āϤāĻž āĻāϞā§āϞā§āĻ āĻāϰā§āĻāĻŋāĨ¤ āύāĻŋāĻā§āϰ diagnosis āĻāĻāĻāĻŋ retrospective clinical assessment, āĻŦāϰā§āϤāĻŽāĻžāύ āϰā§āĻā§āϰ āύāĻŋāĻļā§āĻāĻŋāϤ diagnosis āύā§āĨ¤
1. Prescription Marking â C/C, O/E, Advice, Investigation & Dx
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻ āĻāĻļāĻā§āϞ⧠āĻāϞāĻžāĻĻāĻž āϰāĻā§āϰ āĻŦāĻā§āϏ āĻĻāĻŋā§ā§ āĻāĻŋāĻšā§āύāĻŋāϤ āĻāϰā§āĻāĻŋāĨ¤
Share
đĨ Download Marked Prescription
| Marked colour | Clinical section |
|---|---|
| đ´ Red | Chief complaints and history |
| đĩ Blue | On examination |
| đĸ Green | Doctor's diagnosis |
| đŖ Purple | Advice and investigations |
| đ Orange | Prescribed medicines |
2. C/C â Chief Complaints (āĻĒā§āϰāϧāĻžāύ āĻāĻĒāϏāϰā§āĻ)
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļā§ āύāĻŋāĻā§āϰ āϤāĻĨā§āϝāĻā§āϞ⧠āĻĒā§āĻž āϝāĻžāĻā§āĻā§āĨ¤
| Clinical term | āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ | Reading confidence |
|---|---|---|
| Bowel disturbance | āĻŽāϞāϤā§āϝāĻžāĻā§āϰ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻ āĻā§āϝāĻžāϏ⧠āϏāĻŽāϏā§āϝāĻž | Moderate |
| Insomnia | āĻ āύāĻŋāĻĻā§āϰāĻž āĻŦāĻž āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻž | High |
| Paraesthesia of both lower limbs | āĻāĻā§ āĻĒāĻžā§ā§ āĻāĻŋāύāĻāĻŋāύ āĻŦāĻž āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻ āύā§āĻā§āϤāĻŋ | High |
| Palpitation â probable | āĻŦā§āĻ āϧā§āĻĢā§ āĻāϰāĻž | Lowâmoderate |
| Shivering sensation â probable | āĻļāϰā§āϰ⧠āĻāĻžāĻāĻĒā§āύāĻŋ āĻ āύā§āĻāĻŦ āĻāϰāĻž | Moderate |
| Urinary urgency | āĻšāĻ āĻžā§ āϤā§āĻŦā§āϰ āĻĒā§āϰāϏā§āϰāĻžāĻŦā§āϰ āĻŦā§āĻ | Moderate |
| Burning during urination | āĻĒā§āϰāϏā§āϰāĻžāĻŦā§āϰ āϏāĻŽā§ āĻā§āĻŦāĻžāϞāĻžāĻĒā§ā§āĻž | Moderate |
āĻĒā§āϰāĻĨāĻŽ āϞāĻžāĻāύā§āϰ āϏāĻŽā§āĻĒā§āϰā§āĻŖ āĻŦāĻā§āϤāĻŦā§āϝ āĻāĻŦāĻ āĻā§ā§āĻāĻāĻŋ āĻļāĻŦā§āĻĻ āĻ āϏā§āĻĒāώā§āĻāĨ¤ IBS-C diagnosis āĻĨā§āĻā§ constipation-āĻāϰ āϧāĻžāϰāĻŖāĻž āĻĒāĻžāĻā§āĻž āϝāĻžā§, āϤāĻŦā§ āĻŽā§āϞ C/C-āϤ⧠āĻŽāϞāϤā§āϝāĻžāĻā§āϰ āĻŦāĻŋāϏā§āϤāĻžāϰāĻŋāϤ āĻŦāĻŋāĻŦāϰāĻŖ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āύā§āĨ¤
āĻāϞā§āϞā§āĻāĻŋāϤ Patient History
HTN āϞā§āĻāĻž āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻ āϰā§āĻĨāĻžā§ āϰā§āĻā§āϰ āĻĒā§āϰā§āĻŦ āĻĨā§āĻā§ āĻāĻā§āĻ āϰāĻā§āϤāĻāĻžāĻĒā§āϰ āĻāϤāĻŋāĻšāĻžāϏ āĻĨāĻžāĻāĻžāϰ āϏāĻŽā§āĻāĻžāĻŦāύāĻž āϰā§ā§āĻā§āĨ¤
āϤāĻŦā§ āĻāĻāĻŋ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻāĻā§āϰ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻž āϰā§āĻā§āϰ medication history āĻĒā§āϰā§ā§āĻāύāĨ¤
3. O/E â On Examination (āĻļāĻžāϰā§āϰāĻŋāĻ āĻĒāϰā§āĻā§āώāĻž)
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻĒāϰāĻŋāώā§āĻāĻžāϰāĻāĻžāĻŦā§ āĻĒāĻžāĻā§āĻž āϝāĻžāĻā§āĻā§:
Blood Pressure: 120/90 mmHg
Clinical interpretation:
- Systolic BP: 120 mmHg
- Diastolic BP: 90 mmHg
āĻāĻāĻŋ āĻāĻāĻŦāĻžāϰā§āϰ āϰāĻā§āϤāĻāĻžāĻĒā§āϰ āĻĒāϰāĻŋāĻŽāĻžāĻĒāĨ¤ āĻļā§āϧ⧠āĻāĻ reading āĻĻāĻŋā§ā§ hypertension-āĻāϰ āĻŦāϰā§āϤāĻŽāĻžāύ āύāĻŋā§āύā§āϤā§āϰāĻŖ āĻŦāĻž diagnosis āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϝāĻžā§ āύāĻžāĨ¤
āĻ āύā§āϝ examination findings-āĻāϰ āĻŽāϧā§āϝ⧠āĻā§ā§āĻāĻāĻŋ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ finding āϞā§āĻāĻž āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āĨ¤ āϤāĻŦā§ āĻļāĻŦā§āĻĻāĻā§āϞ⧠āϏā§āĻĒāώā§āĻ āύ⧠āĻŦāϞ⧠āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ organ-system examination āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻāĻŋāϞ āĻŦāϞ⧠āĻĻāĻžāĻŦāĻŋ āĻāϰāĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
Important: Prostate-āĻāϰ DRE finding āĻŦāĻž ultrasound prostate volume āĻāĻāĻžāύ⧠āϏā§āĻĒāώā§āĻāĻāĻžāĻŦā§ āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤
4. Doctor's Diagnosis â Prescribing Physician's Dx
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āύāĻŋāĻā§āϰ āĻŦāĻžāĻŽ āĻ āĻāĻļā§ āĻāĻŋāĻāĻŋā§āϏāĻ āϏāĻŽā§āĻāĻŦāϤ āϤāĻŋāύāĻāĻŋ diagnosis āϞāĻŋāĻā§āĻā§āύāĨ¤
| No. | Doctor's Dx | āĻŦāĻžāĻāϞāĻž Clinical Meaning | Confidence |
|---|---|---|---|
| 1 | IBS-C | āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝ-āĻĒā§āϰāϧāĻžāύ āĻāϰāĻŋāĻā§āĻŦāϞ āĻŦāĻžāĻā§ā§āϞ āϏāĻŋāύā§āĻĄā§āϰā§āĻŽ | 0.85 |
| 2 | Enlarged Prostate | āĻĒā§āϰā§āϏā§āĻā§āĻ āĻā§āϰāύā§āĻĨāĻŋāϰ āĻāĻāĻžāϰ āĻŦā§āĻĻā§āϧāĻŋ | 0.95 |
| 3 | Anxiety Disorder | āĻāĻĻā§āĻŦā§āĻāĻāύāĻŋāϤ āĻŽāĻžāύāϏāĻŋāĻ āĻŦā§āϝāĻžāϧāĻŋ | 0.90 |
Diagnosis 1: Irritable Bowel Syndrome with Constipation (IBS-C)
āĻāĻāĻŋ āĻ āύā§āϤā§āϰā§āϰ āĻāĻžāϰā§āϝāĻā§āϰāĻŽā§āϰ āĻāĻāĻāĻŋ disorder, āϝā§āĻāĻžāύ⧠āĻŦāĻžāϰāĻŦāĻžāϰ āĻĒā§āĻāĻŦā§āϝāĻĨāĻžāϰ āϏāĻā§āĻā§ āĻŽāϞāϤā§āϝāĻžāĻā§āϰ āϧāϰāύ āĻ āĻāύāϤā§āĻŦā§āϰ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāĻā§ āĻāĻŦāĻ āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāϏā§āϝāĻž āĻšā§āĨ¤
Clinical limitation: IBS-C āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠Rome IV symptom criteria āĻĒā§āϰāĻŖ āĻšāϤ⧠āĻšāĻŦā§āĨ¤ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϏā§āĻ āĻāϤāĻŋāĻšāĻžāϏ āϏāĻŽā§āĻĒā§āϰā§āĻŖ āύā§āĻāĨ¤ āϤāĻžāĻ IBS-C-āĻā§ documented working diagnosis āĻšāĻŋāϏā§āĻŦā§ āϧāϰāĻž āϝāĻĨāĻžāϝāĻĨ, confirmed diagnosis āĻšāĻŋāϏā§āĻŦā§ āύā§āĨ¤
Diagnosis 2: Enlarged Prostate
āĻŦā§āϏā§āĻ āĻĒā§āϰā§āώā§āϰ āĻĒā§āϰāϏā§āϰāĻžāĻŦā§āϰ āϏāĻŽāϏā§āϝāĻž āĻāĻŦāĻ enlarged prostate-āĻāϰ diagnosis Benign Prostatic Hyperplasia (BPH)-āĻāϰ āϏāĻā§āĻā§ āϏāĻžāĻŽāĻā§āĻāϏā§āϝāĻĒā§āϰā§āĻŖāĨ¤
āϤāĻŦā§ enlarged prostate āĻāĻŦāĻ histologically confirmed BPH āĻāĻ āĻŦāĻŋāώ⧠āύā§āĨ¤ Prostate enlargement-āĻāϰ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ urinary symptoms-āĻāϰ āĻ āύā§āϝ āĻāĻžāϰāĻŖāĻ āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧠āĻšāĻŦā§āĨ¤
Diagnosis 3: Anxiety Disorder
āĻ āύāĻŋāĻĻā§āϰāĻž, āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻŦā§āĻ āϧā§āĻĢā§ āĻāϰāĻž āĻāĻŦāĻ āĻāĻĻā§āĻŦā§āĻāĻāύāĻŋāϤ āĻāĻĒāϏāϰā§āĻ anxiety disorder-āĻāϰ āϏāĻā§āĻā§ āϏāĻžāĻŽāĻā§āĻāϏā§āϝāĻĒā§āϰā§āĻŖ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϤāĻŦā§ anxiety disorder-āĻāϰ subtype āύāĻŋāϰā§āϧāĻžāϰāĻŖā§āϰ āĻāύā§āϝ āĻŦāĻŋāϏā§āϤāĻžāϰāĻŋāϤ psychiatric history āĻĒā§āϰā§ā§āĻāύāĨ¤
5. Investigations â āĻĄāĻžāĻā§āϤāĻžāϰ āĻā§ āĻā§ āĻĒāϰā§āĻā§āώāĻž āĻĻāĻŋā§ā§āĻā§āύ?
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āĻŽāĻžāĻāĻāĻžāύ⧠āĻĻā§āĻāĻŋ investigation āϤā§āϞāύāĻžāĻŽā§āϞāĻāĻāĻžāĻŦā§ āĻĒāϰāĻŋāώā§āĻāĻžāϰāĨ¤
1. Colonoscopy
āĻŦāĻžāĻāϞāĻž: āĻŦā§āĻšāĻĻāύā§āϤā§āϰā§āϰ āĻā§āϤāϰ āĻā§āϝāĻžāĻŽā§āϰāĻžāϰ āϏāĻžāĻšāĻžāϝā§āϝ⧠āĻĒāϰā§āĻā§āώāĻžāĨ¤
Purpose:
- Colorectal malignancy āĻŦāĻž polyp āĻŽā§āϞā§āϝāĻžā§āύāĨ¤
- āĻĻā§āϰā§āĻāϏā§āĻĨāĻžā§ā§ bowel symptoms-āĻāϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ structural cause āĻļāύāĻžāĻā§āϤ āĻāϰāĻžāĨ¤
- āĻĒā§āϰā§ā§āĻāύ āĻšāϞ⧠biopsy āύā§āĻā§āĻžāĨ¤
Why relevant? ā§ā§Ļ āĻŦāĻāϰ āĻŦā§āϏ⧠āϰā§āĻā§āϰ bowel habit āĻĒāϰāĻŋāĻŦāϰā§āϤāĻŋāϤ āĻšāϞ⧠āĻļā§āϧ⧠IBS āϧāϰ⧠āύā§āĻā§āĻžāϰ āĻāĻā§ organic pathology āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻāϰā§āϰāĻŋāĨ¤
2. NCV Study of Both Lower Limbs
Full form: Nerve Conduction Velocity Study.
āĻŦāĻžāĻāϞāĻž: āĻāĻā§ āĻĒāĻžā§ā§āϰ āϏā§āύāĻžā§ā§āϰ āĻŦā§āĻĻā§āϝā§āϤāĻŋāĻ āĻĒāϰāĻŋāĻŦāĻžāĻšāĻŋāϤāĻž āĻĒāϰā§āĻā§āώāĻžāĨ¤
Purpose:
- Peripheral neuropathy āĻŽā§āϞā§āϝāĻžā§āύāĨ¤
- Neuropathic symptoms-āĻāϰ āĻĒā§āϰāĻā§āϤāĻŋ āύāĻŋāϰā§āϧāĻžāϰāĻŖāĨ¤
- āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϏāĻžāϰ⧠EMG-āĻāϰ āϏāĻā§āĻā§ āϏā§āύāĻžā§ā§āϰ āϏāĻŽāϏā§āϝāĻžāϰ āĻŽā§āϞā§āϝāĻžā§āύāĨ¤
Additional Note
Advice box-āĻāϰ āύāĻŋāĻā§āϰ āϞā§āĻāĻžāĻāĻŋ āϏāĻŽā§āĻāĻŦāϤ specialist referral-āϏāĻāĻā§āϰāĻžāύā§āϤ, āϤāĻŦā§ āύāĻŋāĻļā§āĻāĻŋāϤāĻāĻžāĻŦā§ āĻĒā§āĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤ āϤāĻžāĻ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ referral āĻŦāĻž procedure-āĻāϰ āύāĻžāĻŽ āĻ āύā§āĻŽāĻžāύ āĻāϰ⧠āϝā§āĻā§āϤ āĻāϰāĻāĻŋ āύāĻžāĨ¤
6. Prescribed Drug Analysis â MedEx Bangladesh
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻŽā§āĻ āĻĒāĻžāĻāĻāĻāĻŋ āĻāώā§āϧ āĻĒāĻžāĻā§āĻž āϝāĻžāĻā§āĻā§āĨ¤
| No. | Brand Name | Generic Name | Strength |
|---|---|---|---|
| 1 | Motigut | Domperidone Maleate | 10 mg |
| 2 | Timotor | Trimebutine Maleate | 100 mg |
| 3 | Lubilax | Lubiprostone | Strength unclear |
| 4 | Nexcital | Escitalopram Oxalate | 10 mg |
| 5 | Uromax-D | Tamsulosin + Dutasteride | 0.4 mg + 0.5 mg |
āĻŦā§āϰā§āϝāĻžāύā§āĻĄāĻā§āϞā§āϰ spelling āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻ MedEx āĻŽāĻŋāϞāĻŋā§ā§ āύāĻŋāϰā§āϧāĻžāϰāĻŖ āĻāϰāĻž āĻšā§ā§āĻā§āĨ¤
1. Motigut 10 mg Tablet
Bangladesh Brand Name: Motigut 10 mg
Manufacturer: Square Pharmaceuticals PLC
Generic Name: Domperidone Maleate 10 mg
MedEx Therapeutic Class: Motility Stimulants; Motility stimulants/Dopamine antagonist; Prokinetic drugs.
Pharmacological Class: Peripheral dopamine Dâ-receptor antagonist.
Use of Purpose:
Domperidone āĻĒā§āϰāϧāĻžāύāϤ nausea, vomiting āĻāĻŦāĻ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ upper gastrointestinal motility-related symptoms-āĻāϰ āĻāĻŋāĻāĻŋā§āϏāĻžā§ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§āĨ¤
Why Doctor Prescribed This Drug:
āϰā§āĻā§āϰ gastrointestinal symptoms āĻŦāĻŋāĻŦā§āĻāύāĻžā§ dyspepsia āĻŦāĻž upper abdominal discomfort āĻāĻĒāĻļāĻŽā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻāώā§āϧāĻāĻŋ āĻĻā§āĻā§āĻž āĻšā§ā§ āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϤāĻŦā§ āĻāĻāĻŋ IBS-C āĻŦāĻž āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝā§āϰ āĻŽā§āϞ āĻāĻŋāĻāĻŋā§āϏāĻž āύā§āĨ¤
Available Composition: Tablet 10 mg, suspension 5 mg/5 mL āĻāĻŦāĻ paediatric drops 5 mg/mLāĨ¤
Price:
- Unit Price: ā§ŗ4.00
- Strip Price (10 tablets): ā§ŗ40.00
Important safety consideration: āĻŦā§āϏā§āĻ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠Domperidone-āĻāϰ cardiac arrhythmia āĻ QT prolongation-āĻāϰ āĻā§āĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖāĨ¤ āĻŦāϰā§āϤāĻŽāĻžāύ āĻāĻāϰā§āĻĒā§ā§ regulatory advice āĻ āύā§āϝāĻžā§ā§ āĻāĻāĻŋ āĻŽā§āϞāϤ nausea āĻ vomiting-āĻāϰ āϏā§āĻŦāϞā§āĻĒāĻŽā§ā§āĻžāĻĻāĻŋ āĻāĻŋāĻāĻŋā§āϏāĻžā§ āϏā§āĻŽāĻŋāϤ āϰāĻžāĻāĻž āĻšā§āĨ¤
2. Timotor 100 mg Tablet
Bangladesh Brand Name: Timotor 100 mg
Manufacturer: Square Pharmaceuticals PLC
Generic Name: Trimebutine Maleate 100 mg
MedEx Therapeutic Class: Anticholinergics.
Pharmacological Class: Gastrointestinal motility regulator and noncompetitive spasmolytic agent.
Use of Purpose:
Trimebutine āĻ āύā§āϤā§āϰā§āϰ āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ motility āύāĻŋā§āύā§āϤā§āϰāĻŖ āĻāĻŦāĻ IBS-associated abdominal discomfort āĻāĻĒāĻļāĻŽā§āϰ āĻāύā§āϝ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§āĨ¤
Why Doctor Prescribed This Drug:
āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ IBS-C diagnosis-āĻāϰ āϏāĻā§āĻā§ āĻāĻāĻŋ āϏāĻžāĻŽāĻā§āĻāϏā§āϝāĻĒā§āϰā§āĻŖāĨ¤ āĻŦāĻŋāĻļā§āώāϤ āĻĒā§āĻāĻŦā§āϝāĻĨāĻž, cramping āĻŦāĻž intestinal motility disturbance āĻĨāĻžāĻāϞ⧠symptomatic relief-āĻāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻĻā§āĻā§āĻž āĻšā§ā§ āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϤāĻŦā§ Trimebutine IBS-C-āĻāϰ āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝā§āϰ āĻāύā§āϝ guideline-preferred primary laxative āύā§āĨ¤
Available Composition: 100 mg tablet.
Price:
- Unit Price: ā§ŗ6.00
- Strip Price (10 tablets): ā§ŗ60.00
Bangladesh Alternative Brands: Trimotil 100 mg āĻāĻŦāĻ Tritin 100 mgāĨ¤
3. Lubilax Capsule
Bangladesh Brand Name: Lubilax
Manufacturer: Beacon Pharmaceuticals PLC
Generic Name: Lubiprostone.
MedEx Therapeutic Class: Other laxative preparations.
Pharmacological Class: Intestinal chloride-channel activator; secretagogue.
Use of Purpose:
Lubiprostone āĻ āύā§āϤā§āϰ⧠āϤāϰāϞ āύāĻŋāĻāϏāϰāĻŖ āĻŦāĻžā§āĻŋā§ā§ āĻŽāϞ āύāϰāĻŽ āĻāϰāϤ⧠āĻāĻŦāĻ bowel movement āϏāĻšāĻ āĻāϰāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰā§āĨ¤
āĻāĻāĻŋ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§:
- Chronic Idiopathic Constipation (CIC)
- Opioid-Induced Constipation
- IBS-C â āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻ āύā§āĻŽā§āĻĻāĻŋāϤ āϰā§āĻā§āĻā§āώā§āĻ ā§āϤā§
Why Doctor Prescribed This Drug:
āϰā§āĻā§āϰ āĻĒā§āϰāϧāĻžāύ gastrointestinal āϏāĻŽāϏā§āϝāĻž āϝāĻĻāĻŋ chronic constipation āĻšā§, āϤāĻžāĻšāϞ⧠Lubiprostone āĻĻā§āĻā§āĻžāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ āϝā§āĻā§āϤāĻŋāĻāĨ¤
Available Composition and Price:
| Strength | Unit Price | Strip Price |
|---|---|---|
| Lubilax 8 mcg | ā§ŗ15.05 | ā§ŗ150.50 |
| Lubilax 24 mcg | ā§ŗ40.12 | ā§ŗ401.20 |
Important: āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠Lubilax-āĻāϰ strength āĻĒāϰāĻŋāώā§āĻāĻžāϰ āύā§āĨ¤
āĻāĻāĻāύ āĻĒā§āϰā§āώ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠IBS-C-āĻāϰ āĻāύā§āϝ 8 mcg dosing-āĻāϰ FDA approval āύā§āĻāĨ¤ āϤāĻŦā§ āĻĒā§āϰāĻžāĻĒā§āϤāĻŦā§āϏā§āĻāĻĻā§āϰ Chronic Idiopathic Constipation-āĻāϰ āĻāύā§āϝ 24 mcg twice daily āĻāĻāĻāĻŋ āĻ āύā§āĻŽā§āĻĻāĻŋāϤ regimenāĨ¤
āϏā§āϤāϰāĻžāĻ āϰā§āĻā§āϰ āϏāĻ āĻŋāĻ diagnosis āĻāĻŦāĻ prescribed strength āϝāĻžāĻāĻžāĻ āĻāϰāĻž āĻāϰā§āϰāĻŋāĨ¤ Mechanical bowel obstruction āĻĨāĻžāĻāϞ⧠Lubiprostone āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āϝāĻžāĻŦā§ āύāĻžāĨ¤
4. Nexcital 10 mg Tablet
Bangladesh Brand Name: Nexcital 10 mg
Manufacturer: UniMed UniHealth Pharmaceuticals Ltd.
Generic Name: Escitalopram Oxalate 10 mg
MedEx Therapeutic Class: SSRIs & related anti-depressant drugs.
Pharmacological Class: Selective Serotonin Reuptake Inhibitor (SSRI).
Use of Purpose:
Escitalopram āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§:
- Major Depressive Disorder
- Generalized Anxiety Disorder
- Panic Disorder
- Social Anxiety Disorder
- Obsessive-Compulsive Disorder
Why Doctor Prescribed This Drug:
āĻāĻŋāĻāĻŋā§āϏāĻ Anxiety Disorder āϞāĻŋāĻā§āĻā§āύāĨ¤ āϤāĻžāĻ anxiety symptoms āύāĻŋā§āύā§āϤā§āϰāĻŖā§āϰ āĻāύā§āϝ Escitalopram āĻĻā§āĻā§āĻž āĻšā§ā§āĻā§ āĻŦāϞ⧠āĻŽāύ⧠āĻšāĻā§āĻā§āĨ¤
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻĒā§āϰāĻĨāĻŽā§ āϏāĻŽā§āĻāĻŦāϤ ÂŊ tablet āĻāĻŦāĻ āĻĒāϰ⧠⧧ tablet āĻĻā§āύāĻŋāĻ āύā§āĻā§āĻžāϰ āύāĻŋāϰā§āĻĻā§āĻļ āϰā§ā§āĻā§āĨ¤ āϤāĻŦā§ āĻŽā§āϞ dose schedule āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āϞāĻŋāĻāĻŋāϤ āĻāĻĻā§āĻļ āĻĨā§āĻā§ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
Available Composition: 5 mg āĻ 10 mg tablets.
Price:
- Unit Price: ā§ŗ13.00
- Strip Price (10 tablets): ā§ŗ130.00
Important: āĻŦā§āϏā§āĻ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠Escitalopram-āĻāϰ starting dose, serum sodium, QT risk āĻāĻŦāĻ āĻ āύā§āϝ āĻāώā§āϧā§āϰ āϏāĻā§āĻā§ interaction āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻāϰā§āϰāĻŋāĨ¤
5. Uromax-D Capsule
Bangladesh Brand Name: Uromax-D
Manufacturer: UniMed UniHealth Pharmaceuticals Ltd.
Generic Composition:
- Tamsulosin Hydrochloride 0.4 mg
- Dutasteride 0.5 mg
MedEx Therapeutic Class: BPH/ Urinary retention/ Urinary incontinence.
Pharmacological Classes:
- Tamsulosin â Selective Îąâ-adrenergic receptor antagonist
- Dutasteride â 5Îą-reductase inhibitor
Use of Purpose:
Tamsulosin āĻĒā§āϰā§āϏā§āĻā§āĻ āĻ bladder neck-āĻāϰ smooth muscle relax āĻāϰ⧠āĻĒā§āϰāϏā§āϰāĻžāĻŦā§āϰ āĻĒā§āϰāĻŦāĻžāĻš āϏāĻšāĻ āĻāϰā§āĨ¤
Dutasteride dihydrotestosterone āĻā§āĻĒāĻžāĻĻāύ āĻāĻŽāĻŋā§ā§ āĻĻā§āϰā§āĻāĻŽā§ā§āĻžāĻĻā§ prostate volume āĻāĻŽāĻžāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰā§āĨ¤
Why Doctor Prescribed This Drug:
āϰā§āĻā§āϰ Enlarged Prostate diagnosis āĻāĻŦāĻ urinary complaints-āĻāϰ āϏāĻā§āĻā§ āĻāώā§āϧāĻāĻŋāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āϏāĻžāĻŽāĻā§āĻāϏā§āϝāĻĒā§āϰā§āĻŖāĨ¤
āĻāĻāĻŋ āĻŦāĻŋāĻļā§āώāĻāĻžāĻŦā§ āĻŦāĻŋāĻŦā§āĻāĻŋāϤ āĻšā§ āϝāĻāύ BPH-related moderate-to-severe LUTS āĻāĻŦāĻ disease progression-āĻāϰ āĻā§āĻāĻāĻŋ āĻĨāĻžāĻā§āĨ¤
Price:
- Unit Price: ā§ŗ23.00
- 5 capsules-āĻāϰ āĻāύā§āĻŽāĻžāύāĻŋāĻ strip price: ā§ŗ115.00
Available Similar Brands: Maxrin D, Prostacin D, Uroflo Plus, Urocap-D āĻ Uropass-DāĨ¤
Uromax-D and Alternative Brands â MedEx
Clinical caution: Tamsulosin-āĻāϰ āĻāĻžāϰāĻŖā§ orthostatic hypotension āĻ dizziness āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ Dutasteride āĻŦā§āϝāĻŦāĻšāĻžāϰ⧠PSA interpretation āĻĒāϰāĻŋāĻŦāϰā§āϤāĻŋāϤ āĻšā§ āĻāĻŦāĻ prostate size āĻ symptom response āĻŽā§āϞā§āϝāĻžā§āύ⧠āĻĻā§āϰā§āĻāĻŽā§ā§āĻžāĻĻāĻŋ follow-up āĻĒā§āϰā§ā§āĻāύāĨ¤
7. â ī¸ Critical Prescription Safety Review
Potentially Important Drug Interaction
Motigut (Domperidone) + Nexcital (Escitalopram)
āĻāĻ combination-āĻ āĻĻā§āĻāĻŋ āĻāώā§āϧāĻ QT interval āĻĻā§āϰā§āĻāĻžā§āĻŋāϤ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻŦāĻŋāĻļā§āώāϤ ā§ā§Ļ āĻŦāĻāϰ āĻŦā§āϏ⧠āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰā§:
- Cardiac arrhythmia
- Syncope
- Torsades de pointes-āĻāϰ āĻŽāϤ⧠āĻā§āϰā§āϤāϰ ventricular arrhythmia
āĻāϰ āĻā§āĻāĻāĻŋ āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
Clinical assessment: āĻŦāϰā§āϤāĻŽāĻžāύ EMA āĻ MHRA safety recommendations āĻ āύā§āϝāĻžā§ā§, QT-prolonging āĻāώā§āϧā§āϰ āϏāĻā§āĻā§ Domperidone-āĻāϰ āϏāĻšāĻŦā§āϝāĻŦāĻšāĻžāϰ contraindicated āĻšāĻŋāϏā§āĻŦā§ āĻŦāĻŋāĻŦā§āĻāĻŋāϤāĨ¤ Escitalopram-āĻāϰ āĻā§āώā§āϤā§āϰā§āĻ QT-prolonging āĻāώā§āϧā§āϰ āϏāĻā§āĻā§ combination āĻā§āĻžāύā§āϰ āύāĻŋāϰā§āĻĻā§āĻļ āϰā§ā§āĻā§āĨ¤
Recommended action: āϰā§āĻā§ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āĻāĻ āĻāώā§āϧāĻā§āϞ⧠āĻā§ā§ā§ āĻĨāĻžāĻāϞ⧠prescribing physician-āĻāϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻĻā§āϰā§āϤ medication reconciliation āĻāĻŦāĻ āĻŦāĻŋāĻāϞā§āĻĒ āĻāĻŋāĻāĻŋā§āϏāĻž āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤ ECG āĻ serum electrolytes āĻĒāϰā§āĻā§āώāĻž āĻŦāĻŋāĻŦā§āĻā§āϝāĨ¤
āĻāĻāĻŋ āĻĒā§āϰā§āύ⧠āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻšāĻā§āĻžā§ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒā§āύāϰā§āĻŽā§āϞā§āϝāĻžā§āύ āĻāĻžā§āĻž āĻāώā§āϧāĻā§āϞ⧠āύāϤā§āύ āĻāϰ⧠āĻļā§āϰ⧠āĻāϰāĻž āĻāĻāĻŋāϤ āύā§āĨ¤
8. My Clinical Working Assessment
Doctor's Dx āĻŦāύāĻžāĻŽ Independent Clinical Assessment
| Clinical condition | Doctor's Dx | My assessment | Agreement |
|---|---|---|---|
| IBS-C | IBS-C | Suspected IBS-C; CIC remains an important alternative | Partial |
| Enlarged Prostate | Enlarged Prostate | Probable BPH-associated LUTS | Substantial |
| Anxiety Disorder | Anxiety Disorder | Possible anxiety disorder requiring formal assessment | Partial |
| Bilateral leg paraesthesia | No definite diagnosis visible | Peripheral neuropathy to be evaluated | Not separately established |
1. IBS-C versus Chronic Idiopathic Constipation
āĻāĻŋāĻāĻŋā§āϏāĻ IBS-C āϞāĻŋāĻā§āĻā§āύāĨ¤
āĻāĻŋāύā§āϤ⧠IBS-C āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻžāϰ āĻāύā§āϝ recurrent abdominal pain-āĻāϰ āϏāĻā§āĻā§ stool frequency āĻ āĻĨāĻŦāĻž stool form āĻĒāϰāĻŋāĻŦāϰā§āϤāύā§āϰ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āϏāĻŽā§āĻĒāϰā§āĻ āĻĨāĻžāĻāϤ⧠āĻšāĻŦā§āĨ¤
āĻāĻāĻžāύ⧠āϤāĻž āϏā§āĻĒāώā§āĻ āύā§āĨ¤
āϏā§āϤāϰāĻžāĻ āĻāĻŽāĻžāϰ āĻŽā§āϞā§āϝāĻžā§āύā§:
IBS-C and CIC are competing possibilities.
āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝ āĻĒā§āϰāϧāĻžāύ āĻāĻĒāϏāϰā§āĻ āĻšāϞā§āĻ recurrent abdominal pain-āĻāϰ āĻāĻĒāϝā§āĻā§āϤ āĻāϤāĻŋāĻšāĻžāϏ āύāĻž āĻĨāĻžāĻāϞ⧠CIC āĻ āϧāĻŋāĻ āĻāĻĒāϝā§āĻā§āϤ diagnosis āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
2. Enlarged Prostate versus BPH
āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ Enlarged Prostate diagnosis-āĻāϰ āϏāĻā§āĻā§ āĻāĻŽāĻŋ āĻāĻāĻŽāϤ āϝ⧠BPH-associated urinary symptoms āĻāĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āϏāĻŽā§āĻāĻžāĻŦāύāĻžāĨ¤
āϤāĻŦā§ prostate volume, DRE, PVR āĻāĻŦāĻ urinary investigations āĻāĻžā§āĻž bladder outlet obstruction āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϝāĻžā§ āύāĻžāĨ¤
3. Anxiety Disorder
āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ diagnosis āϏāĻŽā§āĻāĻžāĻŦā§āϝāĨ¤
āĻāĻŋāύā§āϤ⧠GAD-7 assessment, symptom duration, functional impairment āĻāĻŦāĻ depression screening āĻāĻžā§āĻž āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ anxiety disorder subtype āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϏāĻŽā§āĻāĻŦ āύā§āĨ¤
Additional Clinical Possibility
āĻāĻā§ āĻĒāĻžā§ā§ āĻāĻŋāύāĻāĻŋāύ āĻ āύā§āĻā§āϤāĻŋāϰ āĻāĻžāϰāĻŖā§ Peripheral Neuropathy āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻĒā§āϰā§ā§āĻāύāĨ¤
āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻžāϰāĻŖ:
- Diabetes mellitus
- Vitamin B12 deficiency
- Hypothyroidism
- Chronic kidney disease
- Neurological disorders
āĻāϏāĻŦ āĻā§āĻŦāϞ differential diagnosis; āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻĨā§āĻā§ āĻāĻā§āϞ⧠āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϝāĻžā§ āύāĻžāĨ¤
9. Final Working Clinical Diagnosis
āĻŦāϰā§āϤāĻŽāĻžāύ āϤāĻĨā§āϝā§āϰ āĻāĻŋāϤā§āϤāĻŋāϤ⧠āĻāĻŽāĻŋ āύāĻŋāĻā§āϰ working diagnosis āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻŦāĨ¤
Primary Working Diagnosis:
Suspected IBS-C versus Chronic Idiopathic Constipation (CIC).
Associated Conditions:
Probable Benign Prostatic Enlargement with Lower Urinary Tract Symptoms (LUTS).
Possible Anxiety Disorder with Insomnia.
Bilateral Lower Limb Paraesthesia â Peripheral Neuropathy to be evaluated.
āĻŦāĻžāĻāϞāĻž Diagnosis
ā§§. āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝ-āĻĒā§āϰāϧāĻžāύ āĻāϰāĻŋāĻā§āĻŦāϞ āĻŦāĻžāĻā§ā§āϞ āϏāĻŋāύā§āĻĄā§āϰā§āĻŽ āϏāύā§āĻĻā§āĻš; āĻŦāĻŋāĻāϞā§āĻĒāĻāĻžāĻŦā§ āĻĻā§āϰā§āĻāϏā§āĻĨāĻžā§ā§ āĻ āĻā§āĻāĻžāϤāĻāĻžāϰāĻŖ āĻā§āώā§āĻ āĻāĻžāĻ āĻŋāύā§āϝāĨ¤
⧍. āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻŦāĻŋāύāĻžāĻāύ āĻĒā§āϰā§āϏā§āĻā§āĻ āĻŦā§āĻĻā§āϧāĻŋ āĻāĻŦāĻ āĻāϰ āϏāĻā§āĻā§ āύāĻŋāĻŽā§āύ āĻŽā§āϤā§āϰāύāĻžāϞāĻŋāϰ āĻāĻĒāϏāϰā§āĻāĨ¤
ā§Š. āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻĻā§āĻŦā§āĻāĻāύāĻŋāϤ āĻŽāĻžāύāϏāĻŋāĻ āĻŦā§āϝāĻžāϧāĻŋ āĻ āĻ āύāĻŋāĻĻā§āϰāĻžāĨ¤
ā§Ē. āĻāĻā§ āĻĒāĻžā§ā§ āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻ āύā§āĻā§āϤāĻŋ; āĻĒā§āϰāĻŋāĻĢā§āϰāĻžāϞ āύāĻŋāĻāϰā§āĻĒā§āϝāĻžāĻĨāĻŋ āĻŽā§āϞā§āϝāĻžā§āύ āĻĒā§āϰā§ā§āĻāύāĨ¤
Diagnostic Confidence
| Assessment | Confidence |
|---|---|
| Prescription contains IBS-C as a working Dx | 0.85 |
| Enlarged prostate is documented | 0.95 |
| Anxiety disorder is documented | 0.90 |
| Actual IBS-C diagnosis is confirmed | Insufficient evidence |
| Actual BPH-related obstruction is confirmed | Insufficient evidence |
| Peripheral neuropathy is confirmed | Insufficient evidence |
āĻāĻāĻžāύ⧠āϏāĻāĻā§āϝāĻžāĻā§āϞ⧠āĻŽā§āϞāϤ handwriting interpretation-āĻāϰ confidence, āϰā§āĻ āύāĻŋāϰā§āĻŖā§ā§āϰ āĻĒāϰāĻŋāϏāĻāĻā§āϝāĻžāύāĻāϤ probability āύā§āĨ¤
10. Further Investigations â Recommended
Gastrointestinal Assessment
- CBC â Anaemia āĻļāύāĻžāĻā§āϤ āĻāϰāĻžāϰ āĻāύā§āϝāĨ¤
- TSH â Hypothyroidism-associated constipation āĻŽā§āϞā§āϝāĻžā§āύā§āĨ¤
- Serum calcium āĻ electrolytes â Metabolic contributors āĻŽā§āϞā§āϝāĻžā§āύā§āĨ¤
- Colonoscopy â āĻŦā§āϏ, screening history āĻ alarm features āĻ āύā§āϝāĻžā§ā§āĨ¤
- Stool occult blood/FIT â āĻĒā§āϰāĻžāϏāĻā§āĻāĻŋāĻ clinical indication āĻ āύā§āϝāĻžā§ā§āĨ¤
Urological Assessment
- Urine R/M/E
- Urine culture â UTI āϏāύā§āĻĻā§āĻš āĻšāϞā§āĨ¤
- Serum creatinine/eGFR
- USG KUB with prostate volume and post-void residual urine
- PSA â Shared decision-making āĻ management relevance āĻ āύā§āϝāĻžā§ā§āĨ¤
- Uroflowmetry
EAU Guidelines āĻ āύā§āϝāĻžā§ā§ male LUTS āĻŽā§āϞā§āϝāĻžā§āύ⧠history, symptom scoring, urinalysis, examination āĻāĻŦāĻ post-void residual assessment āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖāĨ¤
Neurological Assessment
- NCV study
- HbA1c
- Serum vitamin B12
- TSH
- Renal function
- Neurological examination; āĻĒā§āϰā§ā§āĻāύ⧠EMG
11. Bangladesh Clinical Practice â Commonly Used Medicines
āύāĻŋāĻā§āϰ āĻāώā§āϧāĻā§āϞ⧠āĻāĻ āϧāϰāύā§āϰ āϰā§āĻā§āϰ āĻāĻŋāĻāĻŋā§āϏāĻžā§ āĻŦāĻžāĻāϞāĻžāĻĻā§āĻļā§ āĻĒāĻžāĻā§āĻž āϝāĻžā§āĨ¤ āĻāĻā§āϞ⧠āĻāĻāϏāĻā§āĻā§ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āϤāĻžāϞāĻŋāĻāĻž āύā§; āϰā§āĻā§āϰ āϏā§āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ diagnosis, contraindications āĻāĻŦāĻ response āĻ āύā§āϝāĻžā§ā§ āύāĻŋāϰā§āĻŦāĻžāĻāύ āĻāϰāϤ⧠āĻšā§āĨ¤
| Disease | Generic Drug | Bangladesh Brand Examples | Clinical Purpose |
|---|---|---|---|
| IBS-related symptoms | Trimebutine | Timotor, Trimotil, Tritin | Bowel spasm āĻ IBS symptoms |
| Chronic constipation | Lubiprostone | Lubilax, Lubistone, Lubigut | Intestinal fluid secretion āĻŦā§āĻĻā§āϧāĻŋ |
| Chronic constipation | Polyethylene glycol | Generic-specific local brands | Osmotic laxative |
| Chronic constipation | Lactulose | Generic-specific local brands | Stool softening via osmotic action |
| Chronic constipation | Prucalopride | Mopride, Motelity | Colonic motility āĻŦā§āĻĻā§āϧāĻŋ |
| BPH-associated LUTS | Tamsulosin | Uromax, Uroflo, Urocap | Urinary flow improvement |
| BPH-associated LUTS | Dutasteride | Urodart | Prostate volume reduction |
| BPH-associated LUTS | Tamsulosin + Dutasteride | Uromax-D, Maxrin D, Urocap-D | Combination therapy in selected patients |
| Anxiety disorder | Escitalopram | Nexcital, Oxapro, Losita | Anxiety symptoms |
| Anxiety disorder | Sertraline | Generic-specific local brands | Anxiety/depression treatment |
Guideline-based point: AGAâACG 2023 chronic constipation guideline PEG āĻŦā§āϝāĻŦāĻšāĻžāϰ⧠āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠recommendation āĻĻāĻŋā§ā§āĻā§āĨ¤ OTC therapy-āϤ⧠āĻĒāϰā§āϝāĻžāĻĒā§āϤ āĻāύā§āύāϤāĻŋ āύāĻž āĻšāϞ⧠Lubiprostone, Linaclotide āĻ āĻĨāĻŦāĻž Prucalopride-āĻāϰ āĻŽāϤ⧠āĻāώā§āϧ clinical context āĻ āύā§āϝāĻžā§ā§ āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āϝāĻžā§āĨ¤
BPH-āĻāϰ āĻā§āώā§āϤā§āϰ⧠Tamsulosin + Dutasteride combination āϏāĻžāϧāĻžāϰāĻŖāϤ enlarged prostate āĻ progression risk āĻĨāĻžāĻāϞ⧠āĻŦā§āĻļāĻŋ āĻāĻĒāϝā§āĻā§āĨ¤
12. Management and Treatment Plan
A. Constipation / Suspected IBS-C
āĻĒā§āϰāĻĨāĻŽā§ Rome IV symptom history āϝāĻžāĻāĻžāĻ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
Management options:
- Dietary fibre gradually increase āĻāϰāĻžāĨ¤
- āĻĒāϰā§āϝāĻžāĻĒā§āϤ hydration āĻŦāĻāĻžā§ āϰāĻžāĻāĻžāĨ¤
- Regular physical activityāĨ¤
- Toilet routine āĻ bowel habit correctionāĨ¤
- āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ soluble fibre āĻŦāĻž PEGāĨ¤
- Refractory constipation-āĻ prescription medication āĻŦāĻŋāĻŦā§āĻāύāĻžāĨ¤
Important: āϰā§āĻā§ āϝāĻĻāĻŋ āĻāĻāύ⧠colonoscopy āύāĻž āĻāϰ⧠āĻĨāĻžāĻā§āύ āĻāĻŦāĻ āύāϤā§āύ bowel symptoms, rectal bleeding, unexplained weight loss āĻŦāĻž anaemia āĻĨāĻžāĻā§, āϤāĻžāĻšāϞ⧠āĻĻā§āϰā§āϤ Gastroenterology assessment āĻĒā§āϰā§ā§āĻāύāĨ¤
B. BPH-associated LUTS
- IPSS assessmentāĨ¤
- Urinalysis āĻ PVRāĨ¤
- Prostate volume measurementāĨ¤
- Alpha-blocker suitability assessmentāĨ¤
- Significant prostate enlargement āĻĨāĻžāĻāϞ⧠5Îą-reductase inhibitor āĻŦāĻŋāĻŦā§āĻāύāĻžāĨ¤
- Treatment response āĻāĻŦāĻ adverse effects follow-upāĨ¤
C. Anxiety Disorder
- GAD-7 assessmentāĨ¤
- Depression screeningāĨ¤
- Sleep assessmentāĨ¤
- Cognitive Behavioural Therapy (CBT) āĻŦāĻŋāĻŦā§āĻāύāĻžāĨ¤
- āĻĒā§āϰā§ā§āĻāύ āĻšāϞ⧠SSRI therapyāĨ¤
- Elderly patient-āĻāϰ āĻā§āώā§āϤā§āϰ⧠ECG, electrolytes āĻ drug interaction reviewāĨ¤
13. Which Specialist Should Be Consulted?
| Clinical Problem | Recommended Specialist |
|---|---|
| IBS-C / Chronic Constipation | Gastroenterologist |
| Enlarged Prostate / Urinary Symptoms | Urologist |
| Anxiety Disorder | Psychiatrist |
| Bilateral Leg Paraesthesia | Neurologist |
Referral Priority
āĻĒā§āϰāĻĨāĻŽā§ Gastroenterologist āĻāĻŦāĻ Urologist-āĻāϰ āĻŽā§āϞā§āϝāĻžā§āύ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖāĨ¤
āĻāĻžāϰāĻŖ āϰā§āĻā§āϰ āĻŦā§āϏ āĻŦā§āĻļāĻŋ āĻāĻŦāĻ āĻāĻāĻ āϏāĻā§āĻā§ bowel āĻ urinary symptoms āϰā§ā§āĻā§āĨ¤
Neurological symptoms āϝāĻĻāĻŋ persistent āĻŦāĻž progressive āĻšā§, Neurologist assessment āĻĒā§āϰā§ā§āĻāύāĨ¤
āĻĒā§āϰāϏā§āϰāĻžāĻŦ āϏāĻŽā§āĻĒā§āϰā§āĻŖ āĻŦāύā§āϧ āĻšā§ā§ āϝāĻžāĻā§āĻž, āϤā§āĻŦā§āϰ āĻĒā§āĻāĻŦā§āϝāĻĨāĻž, bowel obstruction-āĻāϰ āϞāĻā§āώāĻŖ, āĻ āĻĨāĻŦāĻž āύāϤā§āύ neurological weakness āĻĻā§āĻāĻž āĻĻāĻŋāϞ⧠āĻāϰā§āϰāĻŋ āĻāĻŋāĻāĻŋā§āϏāĻž āĻĒā§āϰā§ā§āĻāύāĨ¤
14. Prescription-Ready Diagnosis Note
āĻāĻĒāύāĻŋ āϰā§āĻā§āϰ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āύāĻŋāĻā§āϰāĻāĻžāĻŦā§ āϞāĻŋāĻāϤ⧠āĻĒāĻžāϰā§āύāĨ¤
Dx:
- Suspected IBS-C vs Chronic Idiopathic Constipation (CIC)
- Probable BPH with LUTS
- Possible Anxiety Disorder with Insomnia
- Bilateral LL Paraesthesia â ?Peripheral Neuropathy
Short Clinical Format
Dx: Suspected IBS-C/CIC + Probable BPH with LUTS + Anxiety Symptoms + Bilateral LL Paraesthesia (under evaluation).
āĻāĻāĻŋāĻ āĻāĻŽāĻžāϰ āĻāĻžāĻā§ āϏāĻŦāĻā§ā§ā§ āϝāĻĨāĻžāϝāĻĨ āϏāĻāĻā§āώāĻŋāĻĒā§āϤ working diagnosis, āĻāĻžāϰāĻŖ āĻāϤ⧠āύāĻŋāĻļā§āĻāĻŋāϤ āύāĻž āĻšāĻā§āĻž āϰā§āĻāĻā§āϞā§āĻā§ confirmed diagnosis āĻšāĻŋāϏā§āĻŦā§ āĻĻā§āĻāĻžāύ⧠āĻšāĻā§āĻā§ āύāĻžāĨ¤
Referral Note
Referred to Gastroenterology for evaluation of chronic bowel symptoms and exclusion of organic pathology. Urology consultation advised for suspected BPH-associated LUTS. Neurology review recommended for bilateral lower-limb paraesthesia.
15. Overview / Summary
āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ āĻāϰ⧠āϤāĻŋāύāĻāĻŋ āĻŽā§āϞ working diagnosis āĻĒāĻžāĻā§āĻž āϝāĻžā§:
IBS-C, Enlarged Prostate āĻāĻŦāĻ Anxiety DisorderāĨ¤
āĻāĻŽāĻžāϰ clinical assessment āĻāĻ diagnoses-āĻāϰ āϏāĻā§āĻā§ āϏāĻžāĻŽāĻā§āϰāĻŋāĻāĻāĻžāĻŦā§ āϏāĻžāĻŽāĻā§āĻāϏā§āϝāĻĒā§āϰā§āĻŖāĨ¤
āϤāĻŦā§ āĻā§ā§āĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻĒāĻžāϰā§āĻĨāĻā§āϝ āϰā§ā§āĻā§āĨ¤
āĻĒā§āϰāĻĨāĻŽāϤ, IBS-C āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻĒā§āϰā§ā§āĻāύā§ā§ symptom criteria āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤ āϤāĻžāĻ CIC-āĻ differential diagnosis-āĻ āϰāĻžāĻāϤ⧠āĻšāĻŦā§āĨ¤
āĻĻā§āĻŦāĻŋāϤā§ā§āϤ, prostate enlargement āϞā§āĻāĻž āĻĨāĻžāĻāϞā§āĻ BPH-related obstruction āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻžāϰ āĻāύā§āϝ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ urological evaluation āĻĒā§āϰā§ā§āĻāύāĨ¤
āϤā§āϤā§ā§āϤ, bilateral lower-limb paraesthesia āĻāϞāĻžāĻĻāĻž neurological assessment āĻĻāĻžāĻŦāĻŋ āĻāϰā§āĨ¤
āϏāĻŦāĻā§ā§ā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ prescribing safety concern āĻšāϞ⧠Domperidone āĻ Escitalopram-āĻāϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ QT-prolonging interactionāĨ¤
16. Actionable Clinical Plan
- Confirm history: Bowel symptoms, urinary symptoms, weight loss, rectal bleeding āĻāĻŦāĻ medication history āĻŦāĻŋāϏā§āϤāĻžāϰāĻŋāϤ āύāĻŋāύāĨ¤
- Investigate: CBC, TSH, HbA1c, electrolytes, kidney function āĻ āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ Colonoscopy āĻāĻŦāĻ NCVāĨ¤
- Evaluate BPH: Urinalysis, prostate volume, PVR, IPSS āĻ āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ PSAāĨ¤
- Medication reconciliation: MotigutâNexcital interaction āϝāĻžāĻāĻžāĻ āĻāϰā§āύ; current therapy āĻšāϞ⧠ECG āĻ electrolyte review āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰā§āύāĨ¤
- Specialist referral: Gastroenterology, Urology āĻāĻŦāĻ neurological findings āĻ āύā§āϝāĻžā§ā§ NeurologyāĨ¤
- Review diagnosis: Investigations āĻ symptom criteria āĻĒā§āϰāĻŖ āĻšāϞ⧠final diagnosis update āĻāϰā§āύāĨ¤
17. References â Textbooks, Guidelines & DOI
A. Standard Medical Textbooks
- Harrison's Principles of Internal Medicine. 22nd Edition. McGraw Hill, 2025. Relevant sections: Functional gastrointestinal disorders, constipation and genitourinary disorders.
- Davidson's Principles and Practice of Medicine. 24th Edition. Elsevier, 2022. Relevant sections: Gastrointestinal and genitourinary medicine.
- Goodman & Gilman's The Pharmacological Basis of Therapeutics. 14th Edition. McGraw Hill, 2023. Relevant sections: Gastrointestinal pharmacology, antidepressants and autonomic pharmacology.
B. Clinical Guidelines
- European Association of Urology (EAU). Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms, 2026.
- American College of Gastroenterology (ACG). Clinical Guideline: Management of Irritable Bowel Syndrome, 2021.
- American Gastroenterological Association / American College of Gastroenterology. Pharmacological Management of Chronic Idiopathic Constipation, 2023.
- European Medicines Agency (EMA). Recommendations restricting domperidone use because of cardiac risk, 2014.
- UK Medicines and Healthcare products Regulatory Agency (MHRA). Citalopram and escitalopram: QT interval prolongation.
C. Peer-Reviewed Journal Articles with DOI
- Lacy BE, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021;116(1):17â44. DOI: 10.14309/ajg.0000000000001036
- Chang L, et al. AGAâACG Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. American Journal of Gastroenterology. 2023;118(6):936â954. DOI: 10.14309/ajg.0000000000002227
- Chang L, et al. Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023;164(7):1086â1106. DOI: 10.1053/j.gastro.2023.03.214
Final Clinical Conclusion
Doctor's Dx: IBS-C + Enlarged Prostate + Anxiety Disorder.
My Working Dx: Suspected IBS-C versus CIC + Probable BPH-associated LUTS + Possible Anxiety Disorder + Bilateral LL Paraesthesia requiring evaluation.
Overall agreement: Substantial agreement with the physician's documented working diagnoses, but insufficient evidence to independently confirm all three conditions.
Md.Rafiqul Islam Lipu